Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Thread monofilament and minoxidil together increase hair growth in female androgenetic alopecia.

Low serum ferritin is linked to hair loss in women.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

AA-PRP injections effectively increase hair count and thickness for male pattern hair loss.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

PRP shows potential for treating female hair loss, but more research needed.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Various treatments exist for hair loss, but more research is needed for better options.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Thicker hair grows faster; hair loss patients have slower growth.

There's no significant genetic link between male pattern baldness and COVID-19.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Systematic reviews on platelet-rich plasma therapy for hair loss have many quality issues.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

New scale reliably assesses male hair loss with female pattern.